Monday, November 16th, 2009
Biofortuna and Lab901 to collaborate on rapid genotyping projects
Lab901 (Edinburgh, UK) and Biofortuna (Liverpool, UK) today announced that they will collaborate on the launch of an automated PCR based diagnostics system for the rapid detection of certain HLA-related diseases such as Coeliac disease. Lab901 will be optimising its automated ScreenTape® PCR diagnostics platform for use with Biofortuna’s range of multiplex PCR diagnostics kits for the detection of Coeliac disease and other HLA-related diseases such as reactive arthritis, diabetes and drug hypersensitivity.
